Navigation Links
LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
Date:12/17/2008

CINCINNATI, Dec. 17 /PRNewswire/ -- The LCA-Vision Full Value Committee, comprised of Dr. Stephen N. Joffe, Craig P.R. Joffe and Alan H. Buckey, today announced that it has sent a letter to the stockholders of LCA-Vision Inc. (NasdaqGS: LCAV). The members of The LCA-Vision Full Value Committee collectively own approximately 11.4% of the Company's outstanding shares.

    The full text of the letter follows:

    A Message from the LCA-Vision Full Value Committee

    ATTENTION LCA-VISION STOCKHOLDERS

    December 17, 2008

    Dear Fellow Stockholder:

    IT IS TIME FOR A CHANGE!

Dr. Stephen N. Joffe, Craig P.R. Joffe and Alan H. Buckey (collectively, "The LCA-Vision Full Value Committee") own in the aggregate approximately 11.4% of the outstanding shares of LCA-Vision, Inc.(NasdaqGS: LCAV) ("LCA-Vision" or the "Company"), making us one of the largest stockholders of the Company. The LCA-Vision Full Value Committee is comprised of the founders and former executive management team of LCA-Vision that helped build the Company from the ground up into the industry leader it once was. In a very short period of time, over 90% of the Company's value has been wiped out under the existing executive management team and Board of Directors of the Company (the "LCA Board"). What's more, the management and Board do not seem to share our serious concerns, or feel any sense of urgency regarding this dramatic decline in the Company's operating and stock performance.

In the two years since Steve Straus was hired as CEO by the Board of Directors in November 2006, LCA-Vision shares have decreased over 90% from $32.71 to $3.12, the closing price on the day before we disclosed our 11.4% position in a filing with the Securities and Exchange Commission. This represents an astounding loss in market capitalization to the Company's stockholders of hundreds of millions of dollars and is simply unacceptable. Regardle
'/>"/>

SOURCE Steve Joffe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Comment of Senator Patrick Leahy (D-Vt.) on President-elect Obamas Choice of Former Senator Tom Daschle to Head The Department of Health and Human Services and A New White House Office of Health Reform
2. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
3. Former Mayor of Indianapolis to Serve as a Senior Strategic Advisor to McKenna Long & Aldridge LLPs Global Infrastructure Finance and Public-Private Partnerships Practice
4. Sweet Surprise: Even Former Critics Dispel Long-Held Myths About High Fructose Corn Syrup
5. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
6. TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
7. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
8. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
9. Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company
10. Former Smoker Celebrates One Year Anniversary of Being a Non-Smoker 60 Pounds Lighter
11. A Place for Mom Hires Former VP of Sales and Marketing of Assisted Living Concepts as Market Development Coach

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Calif., Dec. 3 The Boa...al Studies unanimously voted to elect three new m..., Fred Dotzler is co-founder and Managing Direc...vo is investing $650 million from three funds in e...ies. Dotzler founded Medicus Venture Partners in 1...
(Date:12/3/2009)...A, Calif., Dec. 3 For California,s...sk of disability remains one of the most significa...ll being, but also their business,s viability. ,...en their toll, owners of small businesses are reco...y net with enhanced disability coverage," said Mi...
(Date:12/3/2009)... Fla., Dec. 3 If you have seen "Su... for a stunning look at the other side of the dini... screen her feature documentary, "Supercharge Me! ...ember 8th, 5 p.m. at Sever Hall, Harvard Yard. The...College Tour. The film will be followed by a lectu...
(Date:12/3/2009)..., Pa., Dec. 3 Southern Tier Health...are Inc. (ICW), a global leader in eHealth technol...nents for its Health Information Exchange (HIE). ...ndex (EMPI), Enterprise Master Provider Registry (...ties, 470,000 residents, 8 hospitals, and over 800...
(Date:12/3/2009)... Harmful procedures on young women caused by outd...ch sues FDA on December 11 for blocking new techno...EB) December 2, 2009 -- Now the American College ...hat the invasive cancer workup procedure, also kno...nnecessary to some women who have received the pro...
Breaking Medicine News(10 mins):Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2Health News:Southern Tier HealthLink NY Selects InterComponentWare to Deliver Core Components of HIE 2Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2
...n of Leading Calcium Brand Enriches Consumer Care ...oduct Portfolio, MORRISTOWN, N.J., Oct. 5 Bayer ... Care Division has received regulatory,approvals n...Mission Pharmacal was closed yesterday evening at ...
...POLIS, Oct. 5 Eli Lilly and Company,announced tod... U.S. Food,and Drug Administration (FDA), the comp...mbyax(R) (olanzapine and fluoxetine HCl) U.S. prod...ed pooled analyses of Lilly,s,clinical trial data ...
..., Oct. 5 Cell Therapeutics, Inc. (CTI),(Nasdaq: ...hnology Industry,Organization (BIO) Investor Forum...-11, 2007, at the Palace Hotel in,San Francisco. C...tation. The webcast can be accessed at, http://www...
...AN FRANCISCO, Calif., Oct. 5 Anesiva,Inc. (Nasdaq... the company,s,chief executive officer, will prese...IO InvestorForum 2007" on Thursday, October 11, 20... Investors page, and click on,Events. Please conne...
...Oct. 5 Any well-informed parent knows about the,F...ith cold & flu season,upon us, parents scramble to...gestion. Nosefrida nasal aspirator -- a Swedish pr...ar medicines such as Dimetapp and Triaminic,rarely...
...ent, Health, NGOs, Sports, Academic, and Business ...l-being of Individuals with Intellectual ..., Oct. 5 /Xinhua-PRNewswire-USNewswire/ -- Leaders...pecial Olympics World Summer Games in Shanghai, Ch...
Other Medicine News:Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 2Health News:Bayer HealthCare Cleared to Acquire Citracal(R) 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 2Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 4Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 5Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 6Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 7Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 8Health News:Nosefrida Nasal Aspirator - A Parent's Alternative to Medicines on the Verge of FDA Ban 2Health News:Global Leaders Converge for Special Olympics Global Policy Summit 2Health News:Global Leaders Converge for Special Olympics Global Policy Summit 3Health News:Global Leaders Converge for Special Olympics Global Policy Summit 4
(Date:12/3/2009)... , , PISCATAWAY, N.J., Dec. 3 /PRNew... Bulletin Board: MLSS), the recognized leader in a...at it had entered into a joint venture with China ...arm") and Yichang Humanwell Pharmaceutical Co. Ltd...hina (the "PRC"), to develop orthopedic and epidur...
(Date:12/3/2009)... , , MAPLE GROVE, Minn., Dec. 3 /PRNe...nnounced the next phase of its strategic plan for ...(extended release topiramate), an internally devel...5 is being developed with Upsher-Smith,s proprieta...II clinical trial in early 2010 for the adjunctive...
(Date:12/3/2009)... , , ROCHESTER, N.Y., Dec. 3 /PRNewswire-F...), a leading provider of quantitative imaging for ...itled "System and Method for 4D Reconstruction and...n. ,, VirtualScopics, Vice President of Technol...ated, "We are pleased that Japan has recognized th...
Breaking Medicine Technology:Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Upsher-Smith Announces Milestone in Development of CNS Strategy 2VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3HealthFitness President Gregg O Lehman Named to DMAA Board of Directors 58047 1HealthFitness President Gregg O Lehman Named to DMAA Board of Directors 58047 2Small Steps May Speed Recovery in ICU Patients 58045 1Small Steps May Speed Recovery in ICU Patients 58045 2Hormone Therapy for Prostate Cancer Raises Heart Risks 58043 1Hormone Therapy for Prostate Cancer Raises Heart Risks 58043 2
...mprovement in Personal and Social,Performance,...re/ --,Longer-term treatment with INVEGA(TM) (pa... daily oral medication for,schizophrenia, helped...s and maintain their improvements in personal and ...om a large, open label, international,clinical t...
...WIRE)--Mar 30, 2007 - NEOPHARM, Inc.,(Nasdaq: NEOL...trial in second-line metastatic colorectal cancer ...the active metabolite of irinotecan,(Camptosar(R))...,completion of treatment of the first 21 patients ...not achieve the primary tumor,response endpoint. N...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6NeoPharm Provides Update on LE-SN38 Program 2
Castroviejo Double Ended Lacrimal Dilator
Wheeler Cyclodialysis Spatula
Thornton Phacoemulsification Spatula
Culler Iris Spatula
Medicine Products: